-
Symbol
-
CERO on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.0001 par value per share
-
Latest Disclosed Ownership
-
17K shares
-
Security Ownership
-
0%
YK Bioventures Opportunities GP I, LLC ownership in CERo Therapeutics Holdings, Inc. Common Stock, $0.0001 par value per share (CERO)
2024-12-17 - YK Bioventures Opportunities GP I, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 17K shares of CERo Therapeutics Holdings, Inc. Common Stock, $0.0001 par value per share (CERO).
This represents 0% percent ownership of the company.